Diabetic ketoacidosis in youth with diabetes mellitus during the COVID-19 pandemic
Author:
Cymbaluk Anna12, Huang Xiaofan3, Minard Charles3, DeSalvo Daniel12, Redondo Maria J.12ORCID
Affiliation:
1. Division of Pediatric Diabetes and Endocrinology , Texas Children’s Hospital , Houston , TX , USA 2. Department of Pediatrics , 3989 Baylor College of Medicine , Houston , TX , USA 3. 3989 Institute for Clinical and Translational Research, Baylor College of Medicine , Houston , TX , USA
Abstract
Abstract
Objectives
We sought to determine if the early months of the coronavirus disease 2019 (COVID-19) pandemic influenced pediatric diabetic ketoacidosis (DKA) hospitalization characteristics.
Methods
This is a cross-sectional study of youth with laboratory-confirmed DKA admitted to a large tertiary children’s hospital in the USA. Data were collected from admissions in March through July 2019 and March through July 2020, respectively. We evaluated the clinical characteristics of hospitalization, including demographic data and DKA severity. We used univariable ordinal logistic regression followed by multiple ordinal logistic regression to adjust for potential confounders.
Results
We included 137 children with diabetes admitted for DKA in the relevant period in 2019 and 173 patients admitted for DKA in the same period in 2020. Hemoglobin A1C (HbA1c) upon admission was higher in 2020 (median=12.2 %) than in 2019 (11.5 %, p=0.018). Children who were admitted with DKA in 2020 were less likely to be autoantibody positive than those in 2019 (83 vs. 91 %, p=0.028). In the univariable model, being admitted in 2020 was significantly associated with more severe DKA (p=0.038), as was HbA1c (p=0.001). After adjusting for HbA1c upon admission, admission year was no longer significantly associated with more severe DKA.
Conclusions
In this study of pediatric diabetes of any type and duration of diabetes, youth admitted for DKA at the start of the COVID-19 pandemic, compared with those admitted during the year before, were more likely to have autoantibody-negative diabetes and had significantly higher HbA1c. Additionally, higher HbA1c seemed to mediate more severe DKA during the pandemic.
Publisher
Walter de Gruyter GmbH
Reference33 articles.
1. Yang, X, Yu, Y, Xu, J, Shu, H, Xia, J, Liu, H, et al.. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8:475–81. https://doi.org/10.1016/s2213-2600(20)30079-5. 2. Wu, C, Chen, X, Cai, Y, Xia, J, Zhou, X, Xu, S, et al.. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180:934–43. https://doi.org/10.1001/jamainternmed.2020.0994. 3. Wu, Z, McGoogan, JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239–42. https://doi.org/10.1001/jama.2020.2648. 4. Zhou, F, Yu, T, Du, R, Fan, G, Liu, Y, Liu, Z, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62. https://doi.org/10.1016/s0140-6736(20)30566-3. 5. Bode, B, Garrett, V, Messler, J, McFarland, R, Crowe, J, Booth, R, et al.. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol 2020;14:813–21. https://doi.org/10.1177/1932296820924469.
|
|